A share price of Olema Pharmaceuticals Inc [OLMA] is currently trading at $11.04, up 12.77%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The OLMA shares have gain 32.22% over the last week, with a monthly amount glided 70.63%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Olema Pharmaceuticals Inc [NASDAQ: OLMA] stock has seen the most recent analyst activity on August 12, 2025, when Citigroup reiterated its Buy rating and also boosted its price target to $21 from $20. Previously, Goldman started tracking the stock with Buy rating on April 02, 2024, and set its price target to $24. On January 30, 2024, Citigroup initiated with a Buy rating and assigned a price target of $20 on the stock. Oppenheimer started tracking the stock assigning an Outperform rating and suggested a price target of $21 on July 21, 2023. CapitalOne initiated its recommendation with an Overweight and recommended $16 as its price target on May 05, 2023. Credit Suisse started tracking with an Outperform rating for this stock on February 22, 2023, and assigned it a price target of $12.
Olema Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $2.86 and $13.51. Currently, Wall Street analysts expect the stock to reach $28.5 within the next 12 months. Olema Pharmaceuticals Inc [NASDAQ: OLMA] shares were valued at $11.04 at the most recent close of the market. An investor can expect a potential return of 158.15% based on the average OLMA price forecast.
Analyzing the OLMA fundamentals
Gross Profit Margin for this corporation currently stands at -0.11% with Operating Profit Margin at -431.66%, Pretax Profit Margin comes in at -390.92%, and Net Profit Margin reading is -390.92%. To continue investigating profitability, this company’s Return on Assets is posted at -0.37, Equity is -0.43 and Total Capital is -0.45. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 9.97 points at the first support level, and at 8.91 for the second support level. However, for the 1st resistance point, the stock is sitting at 11.80, and for the 2nd resistance point, it is at 12.57.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Olema Pharmaceuticals Inc [NASDAQ:OLMA] is 15.22. Also, the Quick Ratio is 15.22, while the Cash Ratio stands at 1.58.
Transactions by insiders
Recent insider trading involved Harmon Cyrus, Director, that happened on Sep 18 ’25 when 10000.0 shares were sold. Director, Harmon Cyrus completed a deal on Sep 16 ’25 to sell 10000.0 shares. Meanwhile, Director Harmon Cyrus sold 3086.0 shares on Sep 18 ’25.
